(October 6, 2017, 10:13 AM EDT) -- CHICAGO — An Illinois federal jury on Oct. 5 awarded an AndroGel heart attack plaintiff $140.1 million in a testosterone replacement therapy multidistrict litigation retrial (Jeffrey Konrad, et al. v. AbbVie, Inc., et al., No. 15-966, N.D. Ill.)....